Your browser doesn't support javascript.
loading
CLPTM1L is a GPI-anchoring pathway component targeted by HCMV.
Kol, Inbal; Rishiq, Ahmed; Cohen, Mevaseret; Kahlon, Shira; Pick, Ophir; Dassa, Liat; Stein, Natan; Bar-On, Yotam; Wolf, Dana G; Seidel, Einat; Mandelboim, Ofer.
Afiliação
  • Kol I; The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel Canada, Hadassah-Hebrew University Medical Center , Jerusalem, Israel.
  • Rishiq A; The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel Canada, Hadassah-Hebrew University Medical Center , Jerusalem, Israel.
  • Cohen M; The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel Canada, Hadassah-Hebrew University Medical Center , Jerusalem, Israel.
  • Kahlon S; The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel Canada, Hadassah-Hebrew University Medical Center , Jerusalem, Israel.
  • Pick O; The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel Canada, Hadassah-Hebrew University Medical Center , Jerusalem, Israel.
  • Dassa L; The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel Canada, Hadassah-Hebrew University Medical Center , Jerusalem, Israel.
  • Stein N; The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel Canada, Hadassah-Hebrew University Medical Center , Jerusalem, Israel.
  • Bar-On Y; Department of Immunology, Technion-Israel Institute of Technology, Haifa, Israel.
  • Wolf DG; The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel Canada, Hadassah-Hebrew University Medical Center , Jerusalem, Israel.
  • Seidel E; Clinical Virology Unit, Hadassah Hebrew University Medical Center , Jerusalem, Israel.
  • Mandelboim O; The Concern Foundation Laboratories at the Lautenberg Center for Immunology and Cancer Research, Institute for Medical Research Israel Canada, Hadassah-Hebrew University Medical Center , Jerusalem, Israel.
J Cell Biol ; 222(9)2023 09 04.
Article em En | MEDLINE | ID: mdl-37389656
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Citomegalovirus / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Citomegalovirus / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article